Sustained Vascular Endothelial Growth Factor Blockade by Antivascular Endothelial Growth Factor Antibodies Results in Nonunion in the Process of Fracture Healing in Rabbits
Authors:
- 1 April 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 66 (4) , 1180-1183
Abstract
Objective: To study the role of vascular endothelial growth factor (VEGF) in the process of fracture healing and the effect of VEGF and anti-VEGF polyclonal antibody on fracture healing. Methods: One hundred and five New Zealand white rabbits were subjected to fracture of the middle part of the left radius, and were randomly divided into control, VEGF, and VEGF polyclonal antibody groups. The blood flow at the fracture site was measured by single photoemission computerized tomography after 8 hours, 24 hours, and 72 hours, and 1 weeks, 3 weeks, 5 weeks, and 8 weeks. X-ray films were taken after 1 weeks, 3 weeks, 5 weeks, and 8 weeks to observe the results of fracture healing. Results: The blood flow at the fracture site in the VEGF group significantly increased compared with the control group during 8 hours to 1 week, but no obvious difference was seen on the X-ray films between the two groups. In the VEGF polyclonal antibody group, the blood flow at the fracture sites decreased significantly at all time points compared with the control group. The fracture healing process was disturbed, and nonunion signs were seen at the fracture site. Conclusions: The lack of VEGF may impede the fracture healing process, and results in nonunion at the fracture site.Keywords
This publication has 10 references indexed in Scilit:
- Vascular endothelial growth factor and its receptor expression during the process of fracture healingChinese Journal of Traumatology, 2008
- Human atrophic fracture non‐unions are not avascularJournal of Orthopaedic Research, 2002
- In Vivo Endochondral Bone Formation Using a Bone Morphogenetic Protein 2 Adenoviral VectorHuman Gene Therapy, 1999
- Locally Administered Vascular Endothelial Growth Factor cDNA Increases Survival of Ischemic Experimental Skin FlapsPlastic and Reconstructive Surgery, 1998
- Strongly Enhanced Serum Levels of Vascular Endothelial Growth Factor (VEGF) after Poly-trauma and BurnClinical Chemistry and Laboratory Medicine (CCLM), 1998
- Substantially Attenuated Hemodynamic Responses to Escherichia coli-Derived Vascular Endothelial Growth Factor Given by Intravenous Infusion Compared with Bolus InjectionThe Journal of Pharmacology and Experimental Therapeutics, 1998
- Evaluation of Heterotopic Bone Formation Induced by Squalane and Bone Morphogenetic Protein CompositeClinical Orthopaedics and Related Research, 1997
- Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factorJournal of Vascular Surgery, 1995
- Differential effects of transforming growth factor‐β1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblastsJournal of Cellular Physiology, 1993
- Biodegradable guide for bone regenerationActa Orthopaedica, 1992